OakChart

Doximity Inc

DOCSHealthcare·Health Information Services·USA·Mid·NYSE·Nov 11 • 9:30 AM ET

32.09-0.33 (-1.02%)
2026-11-11 15:30 CET
Market cap
5,778.44 USD m
Revenue, TTM
661.58 USD m
Net income, TTM
139.72 USD m
Free cash flow, TTM
296.78 USD m
EPS diluted, TTM
0.72
P/E
44.63
Compare

Price

DOCS against its 20, 50 and 200-day averages
2050200missearnings
20.0030.0040.0032.7M65.3MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26DOCSclose 32.0920-day 32.9050-day 29.45200-day 25.2432.09

52.2% under 67.10 on 4 Nov 2025. Last 15 sessions, 18.0% high to low

Profile

DOCS
52-week range, 40% of the way up
17.1554.04

Doximity, Inc. engages in the development and operation of an online platform for medical professionals. Its cloud-based software has the ability to enable users to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. The company was founded by Shari Buck, Konstantin Guericke, Nate Gross, and Jeffrey A. Tangney on April 16, 2010 and is headquartered in San Francisco, CA.

IndexRUI
Employees880
IPOJun 24, 2021
Beta1.29
ATR, 14d1.38
Rel volume0.18
Short float5.67%
Insider own31.25%
Inst own72.47%

Snapshot

6 groups

Valuation

IndexRUI
Market Cap5.72B
Enterprise Value5.02B
Income139.72M
Sales661.58M
Book/sh5.21
Cash/sh4.00
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees880
IPOJun 24, 2021

Ratios

P/E44.63
Forward P/E20.76
PEG3.88
P/S8.65
P/B6.16
P/C8.02
P/FCF19.27
EV/EBITDA24.90
EV/Sales7.58
Quick Ratio6.34
Current Ratio6.34
Debt/Eq0.01
LT Debt/Eq0.01
Option/ShortYes / Yes

Earnings

EPS (ttm)0.72
EPS next Y1.55
EPS next Q0.44
EPS this Y-11.92%
EPS next Y15.47%
EPS next 5Y5.35%
EPS past 3/5Y23.05% 52.71%
Sales past 3/5Y15.45% 25.53%
EPS Y/Y TTM-43.66%
Sales Y/Y TTM6.48%
EPS Q/Q-40.18%
Sales Q/Q3.57%
EarningsNov 05 AMC
EPS/Sales Surpr.3.36% 2.17%

Ownership

Insider Own31.25%
Insider Trans-0.07%
Inst Own72.47%
Inst Trans1.89%
ROA11.90%
ROE13.81%
ROIC14.94%
Gross Margin85.59%
Oper. Margin26.68%
Profit Margin21.12%
SMA20-2.48%
SMA508.97%
SMA20027.12%
Trades-

Technical

Shs Outstand127.44M
Shs Float122.53M
Short Float5.67%
Short Ratio2.32
Short Interest6.95M
52W High54.04 -40.62%
52W Low17.15 87.11%
Volatility5.76% 4.35%
ATR (14)1.38
RSI (14)52.01
Beta1.29
Rel Volume0.18
Avg Volume3.00M
Volume27,489

Performance

Perf Week-7.44%
Perf Month5.04%
Perf Quarter20.68%
Perf Half Y37.20%
Perf YTD-27.53%
Perf Year-39.13%
Perf 3Y34.66%
Perf 5Y-58.16%
Perf 10Y-
Recom2.48
Target Price31.16
Prev Close32.42
Price32.09
Change %-1.02%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Aug 10, 2026DowngradeWWells FargoEqual Weight → Underweight$18-43.9%
Jun 29, 2026DowngradeBBofA SecuritiesBuy → Underperform$20-37.7%
May 15, 2026DowngradeBBarclaysOverweight → Equal Weight$20-37.7%
May 14, 2026DowngradeWWells FargoOverweight → Equal Weight$18-43.9%
May 14, 2026DowngradeRRobert W. BairdOutperform → Neutral$18-43.9%
May 14, 2026DowngradeKKeyBanc Capital MarketsOverweight → Sector Weight
May 14, 2026DowngradeJJefferiesBuy → Hold$19-40.8%
May 14, 2026DowngradeBBTIG ResearchBuy → Neutral
Apr 20, 2026DowngradeTTruistBuy → Hold$29-9.6%
Apr 08, 2026DowngradeEEvercore ISIOutperform → In-line$25-22.1%

Peers

Mkt cap
TickerCompanyMkt cap
OPRXOptimizeRx Corp176.12M
VEEVVeeva Systems Inc49.83B
PHRPhreesia Inc774.02M
GDRXGoodRx Holdings Inc1.20B
DHDefinitive Healthcare Corp174.31M
TDOCTeladoc Health Inc1.64B
HSTMHealthstream Inc879.47M
AMWLAmerican Well Corp206.99M
IQVIQVIA Holdings Inc45.64B
ZDZiff Davis Inc1.70B

Insider trading

latest 14 of 44
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Cabral Timothy SDirectorNov 05 '26Sale35.0010,721375,2358,084Nov 09 04:33 PM
TIMOTHY STEPHEN CABRALDirectorNov 05 '26Proposed Sale35.0010,721375,235Nov 05 04:14 PM
Wampler Kira SchererDirectorNov 02 '26Sale32.892,00065,78027,923Nov 04 08:26 PM
KIRA WAMPLERDirectorNov 02 '26Proposed Sale32.892,00065,780Nov 02 04:13 PM
Sitaram SiddharthChief Accounting OfficerOct 14 '26Sale30.682,61380,167101,432Oct 16 06:46 PM
SIDDHARTH SITARAMOfficerOct 14 '26Proposed Sale30.682,61380,167Oct 14 04:07 PM
Wampler Kira SchererDirectorOct 01 '26Sale28.912,00057,82027,923Oct 05 04:08 PM
Yang Watkin Phoebe L.DirectorSep 30 '26Sale26.711,29034,45624,744Oct 02 04:09 PM
KIRA WAMPLERDirectorOct 01 '26Proposed Sale28.912,00057,820Oct 01 04:05 PM
PHOEBE L YANG WATKINDirectorSep 30 '26Proposed Sale26.711,29034,456Sep 30 04:23 PM
Sitaram SiddharthChief Accounting OfficerSep 15 '26Sale26.022,07754,04496,045Sep 16 04:05 PM
SIDDHARTH SITARAMOfficerSep 15 '26Proposed Sale26.022,07754,044Sep 15 04:04 PM
Wampler Kira SchererDirectorSep 01 '26Sale26.332,00052,66027,923Sep 03 04:05 PM
KIRA WAMPLERDirectorSep 01 '26Proposed Sale26.332,00052,660Sep 01 04:09 PM

Held by

AUM
TickerCompanyAUM
IJHiShares Core S&P Mid-Cap ETFAUM: 124.48B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
XMHQInvesco S&P MidCap Quality ETFAUM: 5.81B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
VXFVanguard Extended Market Index ETFAUM: 30.47B
MDYState Street SPDR S&P MIDCAP 400 ETF TrustAUM: 26.22B
IJKiShares S&P Mid-Cap 400 Growth ETFAUM: 10.46B
SPMDState Street SPDR Portfolio S&P 400TM Mid Cap ETFAUM: 18.90B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B

News

latest 14 of 206
  • Doximity, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DOCS (PR Newswire)
  • Doximity earnings analysis: questions answered and next catalysts (Investing.com)
  • Doximity Beats Its Own Guide And Raises Again, But Eroding Retention Metrics Put The AI Reacceleration Story On Trial (Earnings Whispers)
  • Doximity falls as margins decline despite earnings beat (Investing.com)
  • Doximity: Fiscal Q2 Earnings Snapshot (Associated Press)
  • Loading…
  • Doximity Announces Fiscal 2027 Second Quarter Financial Results (Business Wire)
  • Doximity, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DOCS (PR Newswire)
  • Doximity Launches DoseCheck to Catch Dangerous AI Drug Dosing Errors Before They Reach Doctors (Business Wire)
  • Doximity's AI Pivot Faces A Quiet Quarter Before The Back-Half Payoff Arrives (Earnings Whispers)
  • Doximity, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DOCS (PR Newswire) +6.04%
  • OpenEvidence, Doximity settle thorny AI legal battle (Healthcare Dive)
  • Doximity and Wolters Kluwer Sign Partnership to Bring UpToDate to Doximity Ask (Business Wire)
  • Doximity to Release Fiscal 2027 Second Quarter Results on November 5, 2026 (Business Wire) +5.28%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q22026-11-050.3600.3480.180174.54170.8419
2026Q12026-08-060.2900.3030.127156.62151.7718
2025Q42026-05-130.2600.2830.098145.37144.0320
2025Q32026-02-050.4600.4470.309185.05181.6320
2025Q22025-11-060.4500.3790.309168.53157.917
2025Q12025-08-070.3600.3020.265145.91139.5315
2024Q42025-05-150.3800.2720.308138.29133.7318
2024Q32025-02-060.4500.3370.372168.6152.8217
2024Q22024-11-070.3000.2550.220136.83127.1316
2024Q12024-08-080.2800.2230.208126.7119.8816
2023Q42024-05-160.2500.2010.202118.06116.4115
2023Q32024-02-080.2900.2380.239135.28127.513
2023Q22023-11-090.2200.1680.146113.61109.0513
2023Q12023-08-080.1900.1430.134108.4710714
2022Q42023-05-160.2000.1730.144110.97110.099
2022Q32023-02-090.2200.1760.158115.26111.289

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2020FY0.433-0.119206.92-
2021FY0.8200.7680.697343.55339.84
2022FY0.7300.6990.529419.05418.16
2023FY0.9500.8980.717475.42473.82
2024FY1.4201.3101.109570.4565.77
2025FY1.5201.5470.980644.86643.58
2026FY-1.339--680.02
2027FY-1.546--723.18
2028FY-1.777--781.86
2029FY-1.940--830.1
2030FY-2.050--863.1

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-11-061975195.9194.1201.4
2026Q3S2026-11-051921195.14189.7201.4
2026Q3S2026-11-021921195.14189.7201.4
2026Q3S2026-10-211921195.14189.7201.4
2026Q3S2026-10-141991195.14189.7201.4
2026Q3S2026-10-051981194.85188.8201.4
2026Q3S2026-09-251981194.85188.8201.4
2026Q3S2026-09-041971194.48188.8200
2026Q3S2026-08-221870194.29188.8200
2026Q3S2026-08-121970194.62188.8200.6
2026Q3S2026-08-071970194.63188.8200.6
2026Q3S2026-07-281900192.98184.2200.6
2026Q3S2026-07-1419113192.98184.2200.6
2026Q3S2026-07-0720114193.09184.2200.6

Estimate history

EPS, annual0.0030.060.1190.6970.5290.7171.1090.9850.7191
Period20182019202020212022202320242025TTM
EPS, quarterly0.220.3720.3080.2650.3090.3090.0980.1270.185
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual85.695116.388206.897343.548419.052475.422570.399644.863661.58
Period20182019202020212022202320242025TTM
Sales, quarterly136.832168.603138.288145.913168.525185.053145.372156.618174.537
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual181.703181.703181.703192.398193.941186.562188.875183.06178.331
Period20182019202020212022202320242025MRQ
Shares, quarterly186.781187.584188.875187.453188.09184.993183.06179.849178.331
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue661.58644.86570.40475.42419.05343.55206.90116.3985.69
Cost of Goods Sold Incl. D&A95.3570.3355.8750.6753.4939.7931.2014.9010.89
Gross Profit566.23574.54514.52424.75365.56303.76175.70101.4974.81
Selling, General and Administrative Excl. Other389.75352.73283.74251.99239.70190.22122.4079.3367.89
Research and Development154.14130.7093.0481.9880.1962.3543.8732.4427.50
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income176.49221.81230.78172.76125.87113.5453.3022.166.92
Interest Expense0.000.000.000.000.000.000.000.000.00
Unusual Expense2.206.892.988.890.760.000.000.000.00
Net Income Before Taxes203.61250.00263.57185.20133.16114.0057.7723.517.93
Income Taxes63.8953.9540.3937.6220.34-40.787.56-6.220.10
Consolidated Net Income139.72196.05223.19147.58112.82133.2621.5610.830.59
Net Income From Continuing Operations139.72196.05223.19147.58112.82133.2621.5610.830.59
Net Income139.72196.05223.19147.58112.82133.2621.5610.830.59
EPS (Recurring)0.751.011.120.750.530.700.120.060.00
EPS (Basic, Before Extraordinaries)0.761.051.190.780.580.810.120.060.00
EPS (Diluted)0.720.981.110.720.530.700.120.060.00
EBITDA201.45236.19241.44183.03138.18119.7359.4425.067.47
Non-Operating Income (Expense)29.3235.0935.7721.328.050.474.471.351.01
Other After Tax Adjustments0.000.000.000.000.00-21.53-28.65-18.91-7.24
Stock Option Compensation Expense116.6196.0957.1840.3537.7922.955.291.721.56
Price To Earnings Ratio45.0845.0857.9340.5561.2170.7485.93--
Price To Sales Ratio8.047.1920.4711.6516.4928.99---
Gross Margin85.5989.0990.2089.3487.2488.4284.9287.2087.29
Operating Margin26.6834.4040.4636.3430.0433.0525.7619.048.08
Net Margin21.1230.4039.1331.0426.9238.7910.429.300.69
Shares Outstanding178.33183.06188.88186.56193.94192.40181.70181.70181.70
Market Capitalization5,778.445,778.4410,888.585,020.446,268.779,965.559,911.98--

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue174.54156.62145.37185.05168.53145.91138.29168.60
Cost of Goods Sold Incl. D&A29.2527.9919.4118.7016.4315.7914.4714.18
Gross Profit145.29128.63125.97166.35152.10130.12123.82154.42
Selling, General and Administrative Excl. Other101.3494.89101.0292.4984.2175.4474.9774.41
Research and Development41.9638.4839.1134.5930.2026.8024.8022.42
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income43.9533.7324.9573.8667.8954.6948.8580.02
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.030.090.121.974.210.170.170.09
Net Income Before Taxes50.3340.3632.1280.8072.9464.1558.3989.84
Income Taxes15.6016.0513.0119.2410.8810.83-4.0614.64
Consolidated Net Income34.7324.3219.1161.5662.0653.3262.4675.20
Net Income From Continuing Operations34.7324.3219.1161.5662.0653.3262.4675.20
Net Income34.7324.3219.1161.5662.0653.3262.4675.20
EPS (Recurring)0.190.130.100.320.320.270.310.37
EPS (Basic, Before Extraordinaries)0.190.130.100.330.330.280.330.40
EPS (Diluted)0.180.130.100.310.310.270.310.37
EBITDA52.2042.3229.0877.8571.3657.4851.6882.67
Non-Operating Income (Expense)6.416.727.298.909.269.639.719.91
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense32.0529.0329.0326.5023.2817.2714.2715.30
Price To Earnings Ratio45.0821.1419.5735.3262.8055.3957.9361.42
Price To Sales Ratio8.046.057.0513.8323.6320.9320.6519.63
Gross Margin83.2482.1386.6589.8990.2589.1889.5491.59
Operating Margin25.1821.5417.1639.9140.2837.4835.3247.46
Net Margin19.9015.5313.1533.2736.8236.5445.1744.60
Shares Outstanding178.33179.85183.06184.99188.09187.45188.88187.58
Market Capitalization5,778.443,792.774,303.728,336.6413,702.4611,521.3110,888.589,967.91

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments748.60915.66762.90841.00798.11142.5386.45-
Short Term Receivables152.28135.85107.43112.0584.5750.3226.16-
Inventories0.000.000.000.000.000.000.00-
Other Current Assets35.3830.1037.6117.2915.9410.696.95-
Total Current Assets936.261,081.62907.94970.34898.62203.54119.56-
Net Property, Plant & Equipment25.2222.5424.6525.109.578.947.11-
Total Investments and Advances0.000.000.000.000.000.000.00-
Intangible Assets120.3091.0195.2699.7826.8228.510.39-
Deferred Tax Assets40.1267.4152.0541.8451.134.388.83-
Other Assets9.929.126.466.777.788.614.76-
Total Assets1,131.821,271.701,086.351,143.82993.93253.99140.65-
Short Term Debt Incl. Current Port. of LT Debt2.112.212.151.750.640.971.96-
Accounts Payable4.011.362.251.270.461.511.42-
Income Tax Payable1.79-------
Other Current Liabilities147.07152.69142.85136.48110.1899.5652.34-
Total Current Liabilities154.97156.26147.25139.51111.28102.0455.71-
Long Term Debt8.0710.1912.4013.880.450.280.32-
Provision for Risks Charges0.000.000.000.000.000.000.00-
Deferred Tax Liabilities8.137.396.986.932.572.271.73-
Other Liabilities9.8015.2418.3317.381.031.190.29-
Total Liabilities180.98189.08184.95177.70115.34105.7958.06-
Non-Equity Reserves0.000.000.000.000.000.000.00-
Preferred Stock - Carrying Value0.000.000.000.000.0081.4681.46-
Common Equity950.841,082.62901.40966.12878.5966.741.14-
Total Shareholders Equity950.841,082.62901.40966.12878.59148.2082.59-
Accumulated Minority Interest0.000.000.000.000.000.000.00-
Total Equity950.841,082.62901.40966.12878.59148.2082.59-
Total Liabilities & Stockholders Equity1,131.821,271.701,086.351,143.82993.93253.99140.65-
Book Value Per Share5.195.734.834.984.570.370.01-
Tangible Book Value Per Share4.545.254.324.474.430.210.00-
Full-Time Employees880830827977887713--
Price to Book Ratio6.2310.565.796.5011.4111.74--
Return on Assets16.3118.9313.2410.5521.3610.92--
Return on Equity19.2822.5015.8112.2325.9618.68--
Return on Invested Capital20.4520.4216.1511.5115.1614.5213.06-
Quick Ratio6.046.926.176.968.081.992.15-
Current Ratio6.046.926.176.968.081.992.15-

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income139.72196.05223.19147.58112.82154.7850.2129.747.83
Depreciation24.9214.3810.6610.2712.316.206.132.900.55
Other Funds (Non Cash)152.56129.5975.1159.3762.2847.1711.616.938.03
Funds from Operations349.33372.16297.36208.62200.63166.9172.9432.4716.41
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-43.65-45.70-24.10-24.52-21.03-40.3310.03-6.27-1.10
Cash from Operating Activities305.69326.46273.26184.10179.60126.5882.9726.2015.31
Capital Expenditures-8.96-8.96-6.53-5.80-6.18-5.70-4.61-4.24-1.19
Net Assets From Acquisitions0.00-26.530.000.00-53.500.00-31.680.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.004.230.000.00
Purchase or Sale of Investments214.12182.66-22.7736.99-0.24-635.47-38.34-8.85-7.88
Purchase of Investments-304.18-389.16-675.56-472.87-190.56-1,317.19-78.88-79.11-61.73
Sale Or Maturity of Investments518.30571.82652.78509.85190.32681.7240.5470.2653.86
Other Uses0.000.000.000.000.000.00-0.010.000.00
Other Sources0.000.000.000.000.000.590.000.000.00
Cash from Investing Activities205.16147.17-29.3031.19-59.92-640.57-70.42-13.10-9.07
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-420.89-417.98-96.99-264.38-70.64561.235.411.720.98
Repurchase of Common Pref Stock-433.24-431.65-120.29-280.72-85.32-2.70-2.020.000.00
Sale of Common Pref Stock12.3413.6823.3016.3414.69563.938.901.720.98
Proceedsfrom Stock Options3.363.893.573.454.76551.320.000.030.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow-40.58-46.09-34.15-12.15-3.82-0.820.000.000.00
Other Financing Activities Uses-40.58-46.09-34.15-12.15-3.82-0.82-1.470.000.00
Cash from Financing Activities-461.48-464.06-131.14-276.52-74.46560.415.411.720.98
Net Change in Cash49.379.56112.83-61.2445.2246.4217.9614.827.22
Free Cash Flow296.78317.56266.74178.29177.90120.8882.7325.9115.19
Preferred Dividends (Cash Flow)-0.000.000.000.000.00--0.00
Price to Free Cash Flow17.9314.6043.7731.0538.8582.40---
Deferred Taxes & Investment Tax Credit-32.14-11.59-8.5913.23-41.254.99-7.100.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments713.23687.79748.60735.13878.37840.97
Short Term Receivables173.41183.68152.28164.09140.61150.76
Inventories0.000.000.000.000.000.00
Other Current Assets29.7036.1135.3885.3468.4337.40
Total Current Assets916.34907.58936.26984.551,087.401,029.13
Net Property, Plant & Equipment26.1926.0025.2224.5823.6922.71
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets116.42118.36120.30122.24124.1290.01
Deferred Tax Assets26.0723.8440.1214.8415.0755.46
Other Assets6.758.079.9210.816.837.13
Total Assets1,091.771,083.851,131.821,157.031,257.111,204.45
Short Term Debt Incl. Current Port. of LT Debt2.202.142.112.082.122.17
Accounts Payable6.306.494.014.794.391.96
Income Tax Payable4.524.611.79---
Other Current Liabilities131.57137.12147.07142.98133.76155.78
Total Current Liabilities144.59150.36154.97149.85140.27159.91
Long Term Debt6.957.538.078.619.159.67
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities10.208.408.13---
Other Liabilities1.541.489.8019.2712.169.27
Total Liabilities163.29167.78180.98177.73161.58178.85
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity928.48916.07950.84979.301,095.531,025.60
Total Shareholders Equity928.48916.07950.84979.301,095.531,025.60
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity928.48916.07950.84979.301,095.531,025.60
Total Liabilities & Stockholders Equity1,091.771,083.851,131.821,157.031,257.111,204.45
Book Value Per Share5.215.095.195.295.825.47
Tangible Book Value Per Share4.554.444.544.635.164.99
Full-Time Employees--880---
Price to Book Ratio6.233.994.407.6013.3710.70
Return on Assets11.9014.6016.3120.5621.3020.64
Return on Equity13.8117.2119.2823.8224.6124.25
Return on Invested Capital3.712.631.996.235.625.15
Quick Ratio6.346.046.046.577.756.44
Current Ratio6.346.046.046.577.756.44

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income34.7324.3219.1161.5662.0653.32
Depreciation8.218.594.133.993.472.79
Other Funds (Non Cash)40.9636.2340.3435.0330.9023.32
Funds from Operations83.9069.1495.72100.5896.4379.43
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital9.39-27.1513.80-39.69-2.48-17.33
Cash from Operating Activities93.2841.99109.5260.8993.9462.10
Capital Expenditures-1.95-2.38-2.25-2.38-2.37-1.97
Net Assets From Acquisitions0.000.000.000.00-26.530.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-82.08115.37140.2340.60-2.814.65
Purchase of Investments-168.48-14.75-8.04-112.92-128.27-139.93
Sale Or Maturity of Investments86.40130.12148.27153.52125.45144.58
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-84.03112.99137.9838.23-31.712.68
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-52.00-88.55-85.68-194.66-17.68-119.96
Repurchase of Common Pref Stock-54.20-91.63-90.53-196.88-21.89-122.36
Sale of Common Pref Stock2.203.084.842.224.212.40
Proceedsfrom Stock Options1.290.002.080.001.820.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-12.24-12.00-7.48-8.87-12.57-17.18
Other Financing Activities Uses-12.24-12.00-7.48-8.87-12.57-17.18
Cash from Financing Activities-64.24-100.55-93.16-203.53-30.25-137.13
Net Change in Cash-54.9954.43154.34-104.4131.99-72.35
Free Cash Flow91.3339.60107.2758.5891.5860.13
Price to Free Cash Flow17.9313.3514.3128.7147.0542.94

Revenue breakdown

Service, Other2024: 26.63M 2025: 36.45M
Subscription2024: 543.77M 2025: 608.41M
United States2024: 570.40M 2025: 644.86M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-305.67%6.9M122.5M4.40M
2026-10-157.41%9.1M122.5M4.49M
2026-09-309.21%11.3M122.5M4.43M
2026-09-1510.09%12.4M122.7M4.60M
2026-08-3111.44%14.0M122.7M4.69M
2026-08-1415.01%18.4M122.8M5.12M
2026-07-3119.76%24.6M124.3M4.06M
2026-07-1516.60%20.7M124.9M4.09M
2026-06-3015.50%19.7M127.1M4.16M
2026-06-1514.78%18.8M127.0M3.86M
2026-05-2912.82%16.4M127.7M3.77M
2026-05-1512.27%15.7M127.7M3.59M
2026-04-3013.11%17.0M129.7M3.64M
2026-04-1511.61%15.1M129.7M3.53M
2026-03-3110.17%13.2M129.8M3.52M
2026-03-139.85%12.8M129.8M3.50M
2026-02-278.32%10.8M129.8M3.54M
2026-02-137.62%9.9M129.8M3.45M
2026-01-306.63%8.6M130.1M2.64M
2026-01-156.31%8.4M133.6M2.42M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.500.000.0023.81-1.000.00---
call5.000.000.0015.66-1.000.00---
call7.500.000.000.00-0.000.00---
call10.000.000.0023.58-1.000.00---
call12.500.000.009.80-1.000.00---
call15.000.000.0015.90-20.000.00---
call17.500.000.0010.90-16.000.00---
call20.000.000.0013.71-67.000.00---
call22.500.000.008.85-83.000.00---
call25.000.000.007.55-2370.00---
call27.500.000.004.77-2,1100.00---
call30.000.000.002.90-2,2450.00---
call32.500.000.000.90-9500.00---
call35.000.000.000.32-1,6480.00---
call37.500.000.000.20-6260.00---
call40.000.000.000.05-1950.00---
call42.500.000.000.10-42.000.00---
call45.000.000.000.05-2660.00---
call47.500.000.000.02-18.000.00---
call50.000.000.000.30-66.000.00---
call55.000.000.000.15-8890.00---
put2.500.000.000.00-0.000.00---
put5.000.000.000.00-0.000.00---
put7.500.000.000.00-0.000.00---
put10.000.000.000.03-54.000.00---
put12.500.000.000.02-3290.00---
put15.000.000.000.05-77.000.00---
put17.500.000.000.19-4160.00---
put20.000.000.000.02-1,9720.00---
put22.500.000.000.03-8060.00---
put25.000.000.000.04-1,3820.00---
put27.500.000.000.05-1,2430.00---
put30.000.000.000.20-4200.00---
put32.500.000.000.90-7840.00---
put35.000.000.002.50-2020.00---
put37.500.000.006.00-22.000.00---
put40.000.000.007.90-8.000.00---
put42.500.000.009.75-0.000.00---
put45.000.000.0012.20-0.000.00---
put47.500.000.000.00-0.000.00---
put50.000.000.000.00-0.000.00---
put55.000.000.000.00-0.000.00---

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-094Statement of changes in beneficial ownership of securities2026-11-05SEC
2026-11-05144Filing for proposed sale of securities under Rule 144.SEC
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-02144Filing for proposed sale of securities under Rule 144.SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-14SEC
2026-10-14144Filing for proposed sale of securities under Rule 144.SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-01144Filing for proposed sale of securities under Rule 144.SEC
2026-09-30144Filing for proposed sale of securities under Rule 144.SEC
2026-09-284Statement of changes in beneficial ownership of securities2026-09-24SEC
2026-09-164Statement of changes in beneficial ownership of securities2026-09-15SEC
2026-09-15144Filing for proposed sale of securities under Rule 144.SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-028-KCurrent report2026-08-27SEC
2026-09-01144Filing for proposed sale of securities under Rule 144.SEC
2026-08-314Statement of changes in beneficial ownership of securities2026-08-27SEC
2026-08-314Statement of changes in beneficial ownership of securities2026-08-27SEC
2026-08-314Statement of changes in beneficial ownership of securities2026-08-27SEC
2026-08-314Statement of changes in beneficial ownership of securities2026-08-27SEC
2026-08-314Statement of changes in beneficial ownership of securities2026-08-27SEC
2026-08-274Statement of changes in beneficial ownership of securities2026-08-25SEC
2026-08-25144Filing for proposed sale of securities under Rule 144.SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-13SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-13144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-1100441.02K2
2026-1000137.99K2
2026-0900141.16K3
2026-0800387.37K3
2026-070038.14K1
2026-060049.88K1
2026-0500294.04K2
2026-040051.19K1
2026-0300110.83K2
2026-0200138.28K2
2026-010089.30K1
2025-1200101.42K1
2025-1100632.88K2

Institutional holders

Manager% owned
BlackRock, Inc.7.82%
VANGUARD PORTFOLIO MANAGEMENT LLC3.49%
VANGUARD CAPITAL MANAGEMENT LLC3.27%
D. E. Shaw & Co., Inc.3.24%
TWO SIGMA INVESTMENTS, LP2.54%
STATE STREET CORP2.30%
GOLDMAN SACHS GROUP INC2.23%
GEODE CAPITAL MANAGEMENT, LLC2.01%
WELLINGTON MANAGEMENT GROUP LLP1.71%
RENAISSANCE TECHNOLOGIES LLC1.56%

Funds

Fund% owned
iShares Core S&P Mid-Cap ETF2.50%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.30%
VANGUARD SMALL-CAP INDEX FUND1.66%
VANGUARD EXPLORER FUND1.19%
VANGUARD SMALL-CAP GROWTH INDEX FUND0.96%
Federated Hermes MDT Mid Cap Growth Fund0.85%
VANGUARD EXTENDED MARKET INDEX FUND0.84%
Invesco S&P MidCap Quality ETF0.69%
State Street SPDR S&P MidCap 400SM ETF Trust0.56%
ClearBridge Growth Fund0.50%

OakChart. DOCS. Cached 15 minutes.